Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Velcade

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Velcade was produced by Johnson & Johnson and Takeda.

Celgene’s triple multiple myeloma therapy clears phase III trial

Celgene’s triple multiple myeloma therapy clears phase III trial

Known as OPTIMISMM, the study evaluated the efficacy and safety of Pomalyst (pomalidomise) plus Takeda’s Velcade (bortezomib) and low-dose dexamethasone in patients with relapsed or refractory multiple myeloma.

Amgen set for Kyprolis label boost after CHMP backing

Amgen set for Kyprolis label boost after CHMP backing Kyprolis, which was initially approved in the EU two years ago after a few missteps, was recently investigated in a phase III trial that pitted the drug against Takeda’s Velcade ... This time around both Kyprolis and Velcade were studied in combination

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF It is also considering the combination of Janssen’s drug and Takeda’s Velcade (bortezomib) in relapsed or refractory myeloma, and is due to publish its first findings later this year.

SMC gives green light for Amgen’s Kyprolis

SMC gives green light for Amgen’s Kyprolis The trial proved that patients treated with Amgen’s combination had a progression free survival (PFS) of 18.7 months while patients on Millennium’s Velcade (bortexomib) and dexamethasone only saw

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics